Bizarre Patents
An armor with rollers is provided that enables a user to move in all positions by rolling on a hard and smooth surface while constantly varying his bearing points on the ground.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7196049 | Encapsulated fragrance chemicals A polymeric encapsulated fragrance is disclosed which is suitable for use in personal care and cleaning products. In a preferred embodiment of the invention, the fragrance is encapsulated by a first polymer material to form a fragrance encapsulated polymer, the poly... | 03/27/2007 |
| 7196093 | Reversible inhibitors of SAH hydrolase and uses thereof 1. The present invention provides compositions and methods for reversibly inhibiting S-adenosyl-L-homocysteine (SAH) hydrolase. The compounds of the present invention can be used as an anti-hemorrhagic viral infection agent, an immunosuppressant, a homocysteine lowe... | 03/27/2007 |
| 7196054 | Methods for treating wound tissue and forming a supplemented fibrin matrix This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one antimicrobial composition. The composition may be further supplemented with,... | 03/27/2007 |
| 7192736 | Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent Nucleic acid moleucles that encode conjugates containing as a ligand a chemokine receptor targeting agent, such as a chemokine, and a targeted agent, such as a toxin are provided. These conjugates are used to treat inflammatory responses associated with activation, ... | 03/20/2007 |
| 7193084 | Polymorphic form of itraconazole The present invention provides a polymorphic form of itraconazole. ... | 03/20/2007 |
| 7192597 | Composition for treatment of skin, hair and nails A composition, especially for treatment of aged and/or stressed skin, the composition containing, in addition to water, at least one substance that forms lamellar structures with water. The composition further contains S-adenosylmethionine and/or at least one compou... | 03/20/2007 |
| 7192605 | Nucleic acid transfer complexes The present invention relates to compositions and methods for transferring nucleic acids into cells in vitro and in vivo. The compositions comprise a transfection reagent and one or more detergents. In preferred embodiments, the compositions comprise delivery system... | 03/20/2007 |
| 7192616 | Plant extract of the species as NO-synthase inhibitor and uses The invention concerns the use of an efficient amount of at least an extract of an least a plant of the Olea europaea species in a physiologically acceptable medium, in a composition or for preparing a composition, the extract or composition being designed to... | 03/20/2007 |
| 7192731 | Methods for efficient extraction of carotenoids using an esterase A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of ... | 03/20/2007 |
| 7192606 | Drugs for treating viral infections A series of imidodisulfamide derivatives encapsulated in liposomes have been prepared and are useful to treat antiviral infections, especially infections caused by orthopox viruses. ... | 03/20/2007 |
| 7189705 | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers The present invention provides novel and surprisingly effective methods for delivering nucleic acids to cells. These methods are based upon the discovery that the presence of endosomal membrane destabilizers (e.g., calcium) leads to a dramatic increase in the transf... | 03/13/2007 |
| 7189874 | Transfection reagents Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having the general structure: wherein Q is selected from the group consisting of N, O and S... | 03/13/2007 |
| 7189513 | Human papilloma virus immunoreactive peptides This invention provides immunogenic peptides from the HPV-18E6 protein that comprise class I restricted T cell epitopes and discloses methods of administering these peptides to individuals, and a method for monitoring or evaluating an immune response to HPV with the... | 03/13/2007 |
| 7189411 | Peptide/lipid complex formation by co-lyophilization The invention relates to the formation of peptide/lipid vesicles and complexes through the co-lyophilization of peptides, preferably that are able to adopt an amphipathic alphahelical conformation, and one or more lipids. A single solution which solubilizes both the... | 03/13/2007 |
| 7186459 | Liposome coated with polyhydroxyalkanoate and production method thereof A structure, which has both a drug holding capability and a sustained release ability utilizing a liposome and mechanical strength of a polyhydroxyalkanoate. This structure is excellent in holding capability for hydrophilic drugs and other water-soluble substances, ... | 03/06/2007 |
| 7186824 | Reduction inhibitory agent for active-oxygen eliminating activity A reduction inhibitory agent for active-oxygen eliminating activity comprises trehalose as an effective ingredient. A method for inhibiting the reduction of active-oxygen eliminating activity comprises incorporating either trehalose or the reduction inhibitory agent... | 03/06/2007 |
| 7186796 | Method for drying water-borne materials Provided is a method of isolating a bio-molecule from a water-borne mixture, the method comprising: contacting the water-borne mixture with dimethyl ether to form solid particles of the bio-molecule. ... | 03/06/2007 |
| 7186800 | Tumor necrosis factor 6α and 6β The present invention relates to novel Tumor Necrosis Factor Receptor proteins. In particular, isolated nucleic acid molecules are provided encoding the human TNFR-6α & -6β proteins. TNFR-6α & -6β polypeptides are also provided as are vectors, host cells and rec... | 03/06/2007 |
| 7186399 | Methods for targeted drug delivery A method for ligand-based binding of lipid encapsulated particles to molecular epitopes on a surface in vivo or in vitro comprises sequentially administering (a) a site specific ligand activated with a biotin activating agent; (b) an avidin activating agent; and (c)... | 03/06/2007 |
| 7186418 | Composition and use of RAR antagonists for promoting chondrogenesis The invention provides compositions comprising an RAR antagonist for promoting chondrogenesis and methods employing such compositions for treating cartilage and associated bone abnormalities resulting from injury or disease and for ex vivo tissue engineering. ... | 03/06/2007 |
| 7186260 | Medicated wrap A device for treating pain in an injured body member includes a wrap having an interior section which can be loaded with medicament. The wrap also includes at least one inwardly extending nodule adapted to exert pressure on and compress a specific area of the injure... | 03/06/2007 |
| 7186420 | Multi-part substitution infusion fluids and matching anticoagulants A multi-part substitution infusion fluid for an extracorporeal blood treatment and methods for using same are provided. Generally, the multi-part substitution fluid comprises a first solution composed of electrolites but without divalent cations and a second solutio... | 03/06/2007 |
| 7182956 | Stable topical drug delivery compositions A stable composition of a drug comprising a carrier having a phosphatidylcholine component which entraps the drug is applied to the skin for transdermal delivery of the drug. ... | 02/27/2007 |
| 7183262 | Method for selective expression of therapeutic genes by hyperthermia A method for controlling in vivo heat-inducible gene expression for provision of therapeutic polypeptide. The method includes the steps of: (a) providing a construct comprising a polynucleotide encoding a therapeutic polypeptide, wherein the polynucleotide is operat... | 02/27/2007 |
| 7182960 | Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone The present invention relates to a pharmaceutical composition for administration by the nasal route of 17-β-oestradiol and norethisterone. ... | 02/27/2007 |
| 7182933 | Targeting drug/gene carriers to irradiated tissue The present invention provides a biomolecular carrier of pharmaceuticals, comprising: a biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell; and a pharmaceutical. The present invention also provides a method ... | 02/27/2007 |
| 7179482 | Implant device with a retinoid for improved biocompatibility An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant ... | 02/20/2007 |
| 7179484 | Protein-stabilized liposomal formulations of pharmaceutical agents The present invention relates to protein stabilized liposomes. Specifically, the present invention discloses compositions and methods for protein stabilized liposomes, the creation of protein stabilized liposomes, and the administration of protein stabilized liposom... | 02/20/2007 |
| 7179867 | Thermosensitive biodegradable copolymer A thermo-sensitve copolymer of following formula; is disclosed; wherein R1 is hydrogen, or —C(═O)—R2; R2 is C7-30 alkyl substituted or unsubstituted with function... | 02/20/2007 |
| 7179449 | Enhanced ultrasound detection with temperature-dependent contrast agents Methods and devices for enhanced ultrasound detection based upon changing temperature and ultrasound reflectivity of a temperature-dependent contrast agent bound to an ultrasound target are disclosed. The methods and devices can be used for enhanced imaging alone or... | 02/20/2007 |
| 7175850 | Formulation for topical non-invasive application in vivo A formulation comprising molecular arrangements capable of penetrating pores in a barrier, owing to penetrant adaptability, despite the fact that the average diameter of said pores is smaller than the average penetrant diameter, provided that the penetrants can tran... | 02/13/2007 |
| 7175837 | Treatment and composition for achieving skin anti-aging benefits by corneum protease activation Novel methods and compositions for treating aged and environmentally damaged skin are disclosed which provide improvements in the skin's visual appearance, function and clinical/biophysical properties by activating at least one proteolytic enzyme in the skin's strat... | 02/13/2007 |
| 7176191 | Antimicrobial compounds and methods for their use The present invention provides protonated compounds having antimicrobial activity. The invention also provides antimicrobial compositions comprising protonated compounds of the invention. The protonated compounds of the invention provide efficacious antimicrobial ac... | 02/13/2007 |
| 7175831 | Light sensitive compounds for instant determination of organ function Highly hydrophilic indole and benzoindole derivatives that absorb and fluoresce in the visible region of light are disclosed. These compounds are useful for physiological and organ function monitoring. Particularly, the molecules of the invention are useful for opti... | 02/13/2007 |
| 7172893 | Virus vectors and methods of making and administering the same The present invention provides genetically-engineered parvovirus capsids and viruses designed to introduce a heterologous gene into a target cell. The parvoviruses of the invention provide a repertoire of vectors with altered antigenic properties, packaging capabili... | 02/06/2007 |
| 7173010 | Orphanin FQ receptor The present invention provides Orphanin FQ receptor nucleic acids and polypeptides and uses thereof. In particular, the present invention provides nucleic acid sequences of differentially expressed splice variants of the Orphanin FQ receptor. The present invention a... | 02/06/2007 |
| 7173154 | Transfection reagents Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having the general structure: wherein Q is selected from the gro... | 02/06/2007 |
| 7172762 | antigens and vaccine compositions The invention relates to stabilized antigen compositions of Erysipelothrix rhusiopathiae and vaccine formulations containing such antigen compositions. Antigens of the invention are effective in providing long-term protection against erysipelas in animals. | 02/06/2007 |
| 7169382 | Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds A reconstructed epidermis/skin equivalent supplemented with at least one ceramide 7 and/or 5.5 compound, suited for reinforcing the barrier function of normal human epidermis and for improving the barrier function of dry skin and of reconstructed skin or skin equiva... | 01/30/2007 |
| 7169410 | Targeted liposomal drug delivery system A metal targeting complex which associates with a charged liposomal structure is provided. The metal targeting complex provides the targetability of the liposomal construct to the desired receptor sites of a warm-blooded host for therapy or diagnostic use. ... | 01/30/2007 |
